Study S002652

The G Protein-Coupled Receptor Kinase Type 2 Inhibitor Paroxetine as Adjunctive Therapy to Improve Insulin Sensitivity in Patients With Type 2 Diabetes Mellitus

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT06203275
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE3
Masking: NONE
Status: UNKNOWN
Enrollment: 44
Start: 2024-01
Primary completion: 2025-01
Lead sponsor: aya ramadan ashmawy sarhan
Conditions: Diabetes Mellitus, Type 2
Interventions: DRUG:Paroxetine; DRUG:Placebo
Results posted: FALSE

Registered primary outcomes

The primary outcome is the change in glycated Hemoglobin (HbA1c). [3 months]
Change in HOMA-IR . [3 months]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.